Immediate Impact
1 by Nobel laureates 1 from Science/Nature 55 standout
Citing Papers
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH
2025 Standout
Works of Oliver Glass being referenced
Standardisation of diet and exercise in clinical trials of NAFLD-NASH: Recommendations from the Liver Forum
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Oliver Glass | 179 | 251 | 80 | 163 | 21 | 691 | |
| Daisuke Yamaji | 286 | 283 | 106 | 105 | 21 | 638 | |
| Nicholas Jones | 96 | 192 | 55 | 139 | 37 | 771 | |
| Yu-Chih Wu | 141 | 343 | 45 | 101 | 22 | 715 | |
| M Ohkubo | 86 | 310 | 69 | 53 | 16 | 648 | |
| James E. Tate | 164 | 286 | 76 | 213 | 16 | 793 | |
| Jianqiang Ding | 69 | 225 | 32 | 99 | 21 | 663 | |
| Shen Dai | 65 | 320 | 55 | 177 | 17 | 622 | |
| Hairong Chen | 111 | 232 | 42 | 71 | 27 | 674 | |
| Laura Guembe | 97 | 164 | 54 | 132 | 20 | 577 | |
| Da‐Wei Yeh | 195 | 362 | 45 | 74 | 23 | 797 |
All Works
Loading papers...